Polyunsaturated fatty acid regulation of gene transcription: a molecular mechanism to improve the metabolic syndrome.
This review addresses the hypothesis that polyunsaturated fatty acids (PUFA), particularly those of the (n-3) family, play pivotal roles as "fuel partitioners" in that they direct fatty acids away from triglyceride storage and toward oxidation, and that they enhance glucose flux to glycogen. In doing this, PUFA may protect against the adverse symptoms of the metabolic syndrome and reduce the risk of heart disease. PUFA exert their beneficial effects by up-regulating the expression of genes encoding proteins involved in fatty acid oxidation while simultaneously down-regulating genes encoding proteins of lipid synthesis. PUFA govern oxidative gene expression by activating the transcription factor peroxisome proliferator-activated receptor alpha. PUFA suppress lipogenic gene expression by reducing the nuclear abundance and DNA-binding affinity of transcription factors responsible for imparting insulin and carbohydrate control to lipogenic and glycolytic genes. In particular, PUFA suppress the nuclear abundance and expression of sterol regulatory element binding protein-1 and reduce the DNA-binding activities of nuclear factor Y, Sp1 and possibly hepatic nuclear factor-4. Collectively, the studies discussed suggest that the fuel "repartitioning" and gene expression actions of PUFA should be considered among criteria used in defining the dietary needs of (n-6) and (n-3) and in establishing the dietary ratio of (n-6) to (n-3) needed for optimum health benefit.
Clarke
S D
SD
Graduate Program of Nutrition and the Institute of Cell and Molecular Biology, The University of Texas at Austin, Austin, Texas 78712, USA. stevedclarke@mail.utexas.edu
D000818:Animals; D005231:Fatty Acids, Unsaturated / Q000502:physiology*; D006801:Humans; D050356:Lipid Metabolism; D008055:Lipids / Q000037:antagonists & inhibitors; D008659:Metabolic Diseases / Q000235:genetics*; D010084:Oxidation-Reduction; D018160:Receptors, Cytoplasmic and Nuclear / Q000502:physiology; D013577:Syndrome; D014157:Transcription Factors / Q000502:physiology; D014158:Transcription, Genetic / Q000502:physiology*
D005231:Fatty Acids, Unsaturated; D008055:Lipids; D018160:Receptors, Cytoplasmic and Nuclear; D014157:Transcription Factors